DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Determination of Gentamicin Dosing in Neonatal Patients

Information source: Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Infection

Intervention: Gentamicin in Uniject Pre-filled syringe (Drug)

Phase: Phase 4

Status: Active, not recruiting

Sponsored by: Johns Hopkins Bloomberg School of Public Health

Official(s) and/or principal investigator(s):
Gary Darmstadt, MD, Principal Investigator, Affiliation: Johns Hopkins Bloomberg School of Public Health

Summary

The purpose of this study is to determine what dosage of gentamicin for use in one-time administration device (Uniject) is appropriate.

Clinical Details

Official title: Determination of Gentamicin Dosing in Neonatal Patients for Use in the Uniject Pre-Filled Syringe [A Three-Site Study at: 1) Dhaka Shishu Hospital, Dhaka Bangladesh; 2) Christain Medical Center, Vellore, India; and 3) Aga Khan University Medical Center, Karachi, Pakistan]

Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

Patients 2.0-2.24 kg high peak>12.0: 2/6 patients

Low peak<4.0: none

High trough > 2.0: 1/6 patients

Secondary outcome:

Patients 2.5-3.0 kg

High peak>12.0: 2/14 patients

Low peak <4.0: none

High trough>2.0:2/14 patients

Detailed description: This study aims to verify dosages of gentamicin for use in Uniject, chosen based on a consideration of gentamicin pharmacokinetics, safety, efficacy, target population body weight, cost, feasibility and acceptability.

Eligibility

Minimum age: N/A. Maximum age: 28 Days. Gender(s): Both.

Criteria:

Inclusion Criteria:

- infants with culture proven sepsis

- infants 2000-2499 at birth

- infants > 2500 gm at birth

- infants < 2000 gm at birth

- in study site areas: Pakistan, Bangladesh and India

Exclusion Criteria:

- infants w/o culture proven sepsis

Locations and Contacts

Dhaka Shishu Hospital, Dhaka, Bangladesh

Neonatal Intensive Care Unit - Christian Vellore Medical, Vellore, India

Aga Khan, Karachi, Pakistan

Additional Information

Starting date: August 2003
Last updated: September 12, 2005

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017